Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Advertising & Marketing

Sales

Legal & Regulatory

Acquisition & Integration

Goodwill impairment

Restructuring costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Teladoc

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company was founded on June 13, 2002, by George Byron Brooks and Gary Wald and is headquartered in Purchase, NY.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Teladoc reports solid Q4 growth, eyes revenue optimization strategies

Teladoc's Q4 performance showed revenue growth and margin focus, with BetterHelp contributing significantly to profitability.
The company's strategic focus on virtual care expansion and revenue optimization positions Teladoc for continued success in the healthcare market.
While facing internal restructuring challenges, Teladoc's emphasis on growth drivers and operational efficiency presents opportunities for future growth and market leadership.

Teladoc Health excels in Q1, eyes growth and efficiency

Teladoc Health's Q1 performance was strong, with revenue exceeding expectations.
The company is focused on efficiency, innovation, and driving value in virtual care.
BetterHelp segment showed growth and stability, with improving margins expected.
Opportunities exist to capitalize on ad pricing stability and consumer behavior trends.

Teladoc surpasses revenue expectations, focuses on innovation and growth

Teladoc's Q2 performance exceeded expectations, with strong revenue growth and improved margins in both segments. The company's strategic focus on whole-person care, weight management, and AI enhancements positions it well for future growth. Challenges include managing drug costs and private company valuations, while opportunities lie in virtual care demand and strategic M&A.
Teladoc's financial strength, commitment to innovation, and focus on efficiency improvements are key strengths driving its performance. The company's ability to navigate challenges and capitalize on opportunities in the evolving healthcare landscape underscores its resilience and growth potential.

Teladoc Health surpasses Q3 expectations, eyes margin expansion in '24

Teladoc Health's Q3 performance exceeded expectations, driven by revenue growth and margin improvements.
The company is focused on enhancing cost efficiencies, profitability, and driving margin expansion.
Stable pricing environment and strong client demand present opportunities for future growth.
Operational review and strategic initiatives position Teladoc for continued success in the healthcare sector.

Teladoc reports robust 2023 earnings, eyes growth amid marketing challenges

Teladoc delivered strong financial performance in 2023 with notable growth in adjusted EBITDA and revenue. The company faces challenges in BetterHelp marketing yields and delayed consumer engagement efforts.
However, Teladoc's strategic strengths lie in its long-term outlook for revenue growth, margin expansion, and cost-saving initiatives. Opportunities exist in optimizing sales force structure and capital deployment for future growth.
Overall, Teladoc's focus on profitability, growth optimization, and strategic capital allocation positions it well for sustained success in the telehealth industry.

Teladoc Health reports solid Q1 performance amidst revenue challenges

Teladoc Health's Q1 2024 performance showcased revenue growth in Integrated Care but challenges in BetterHelp segment revenue and margin management.
The company's financial strength, product portfolio, and cost initiatives position it well for growth opportunities and strategic market positioning.
Addressing challenges in ad spend management and focusing on international market efficiency are key to unlocking growth potential and improving financial performance.
Overall, Teladoc's performance, strengths, challenges, and opportunities reflect a dynamic landscape with strategic focus on sustainable growth and operational efficiency.

Teladoc Health reports Q2 revenue dip, EBITDA growth; addresses challenges

Teladoc Health's Q2 2024 performance showed mixed results with revenue decline but EBITDA growth. The company is leveraging strengths in patient safety and technology while addressing challenges in customer acquisition costs. Opportunities lie in operational efficiency, insurance coverage access, and international expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002, by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in Purchase, NY.

Canopy Growth

Alphabet

Illumina

PayPal

The trends are your friends with these stocks.

5 Great Stocks to Buy in July

A last minute rally put TDOC in second-place. Teladoc is in a good spot for the rest of 2019 that will only get better.

Best Stocks for 2019: Teladoc Stock Is Here to Stay

We provide a summary of Teladoc's attractive business fundamentals and comment on its addressable market.

Buy Teladoc And Invest In The Pioneering Trailblazer Of Healthcare Of Tomorrow With Conservatively +60% Upside

Teladoc's increasing visits and subscriptions are likely to aid revenue growth. This will further drive its share price.

Teladoc (TDOC) Up 22% in a Year: Will the Rally Continue?

Growth in the demand for telehealth services, combined with a great strategy, should help this stock win over the next decade.

Where Will Teladoc Health Be in 10 Years?

Banking on improving revenues and strategic acquisitions, Teladoc (TDOC) holds great potential to garner benefits for investors.

Why Should You Retain Teladoc (TDOC) in Your Portfolio?

ABIOMED

Amgen

Bristol-Myers

Stryker

These beaten-down healthcare stocks still have plenty of long-term potential. Here's what investors need to know about each.

5 Healthcare Stocks to Pick Up From the Wreckage

Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock?

Teladoc (TDOC) Up 0.1% Since Last Earnings Report: Can It Continue?

DocuSign

Green Dot

Twilio

Twitter

Here are ideas smart investors can use to jump into summer on the right foot.

5 Top Stocks to Buy in  June

Teladoc is a big player in the rapidly rising virtual care market, which is still in the early innings.

Teladoc Health Looks Pretty Interesting

Why Teladoc Could Break Out

Guardant Health Inc

They're leaders in their markets. And those markets should grow tremendously.

Healthcare Stocks I'd Buy Right Now

Micron Technology

Stick with these stocks for the long haul.

Three Top Growth Stocks to Buy

Jumia

Teladoc Health and Jumia Technologies are positioned to profit from two major demographic trends.

Here's Why I Just Bought These 2 High-Growth Stocks

Q1 2019 results narrowly beat expectations. EPS is still negative, but CEO remains bullish, and results are well received. TDOC stock is up marginally.

Teladoc Posts Encouraging Results, But Real Value May Be Realized Through Medicare Advantage

Teladoc's (TDOC) loss in the first quarter can be attributed to higher operating expenses than revenues.

Teladoc Health (TDOC) Surpasses Estimates in Q1 Earnings

Teladoc Health beat Q1 results and now forecasts 2019 revenues of $540 million.

Teladoc: Better Than The Headlines

The telemedicine specialist continues to grow rapidly in the U.S. and abroad.

Teladoc Dials Up 43% Revenue Growth

Teladoc Health Inc. (TDOC) CEO Jason Gorevic on Q1 2019 Results - Earnings Call Transcript

Johnson & Johnson

Pfizer

UnitedHealth Group

There's a clear and present danger to many healthcare stocks that's more serious than anything ever before.

Why This Could Be the Most Dangerous Time Ever to Invest in Healthcare Stocks

Teladoc's (TDOC) Q1 earnings should benefit from increase in revenues, partly offset by rise in expenses.

Teladoc (TDOC) to Report Q1 Earnings: What's in the Cards?

AcelRx Pharmaceuticals

They could be big winners for patient investors.

Three Stocks Peter Lynch Would Love: ACRX, BMY & TDOC

Tableau Software

Anaplan Inc

Here's why now could be the perfect time to add these top stocks to your portfolio.

3  Top Growth  Stocks to Buy in April

iShares U.S. Medical Devices ETF

Intuitive Surgical

Vertex Pharmaceuticals

SPDR S&P Biotech ETF

Health Care Select Sector SPDR Fund

The global demand for healthcare products and services will keep growing significantly. Here's your complete guide to finding the best healthcare stocks and ETFs.

Everything You Need to Know About Investing in Healthcare

Celgene

Healthcare is hot, and these top healthcare stocks could be among the hottest of them all this year.

News for Teladoc Stock (TDOC)